Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.3(PAH):c.1229T>G (p.Phe410Cys)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA229406

102572 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: e9257609-957e-41b4-95ab-02e30f8c924c

Approved on: 2020-07-23

Published on: 2020-07-23

HGVS expressions

NM_000277.3:c.1229T>G

NM_000277.3(PAH):c.1229T>G (p.Phe410Cys)

NM_000277.1:c.1229T>G

NM_000277.2:c.1229T>G

NM_001354304.1:c.1229T>G

NM_001354304.2:c.1229T>G

ENST00000307000.7:c.1214T>G

ENST00000551114.2:n.891T>G

ENST00000553106.5:c.1229T>G

ENST00000635477.1:n.333T>G

ENST00000635528.1:n.744T>G

NC_000012.12:g.102840486A>C

CM000674.2:g.102840486A>C

NC_000012.11:g.103234264A>C

CM000674.1:g.103234264A>C

NC_000012.10:g.101758394A>C

NG_008690.1:g.82117T>G

NG_008690.2:g.122925T>G

Likely Pathogenic

PP4_Moderate PP3 PM2 PM3

PM5

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.1229T>G (p.Phe410Cys) variant in PAH has been detected in two Portuguese patients with moderate PKU (serum Phe = 6.6mg/dL and 15.0mg/dL); BH4 deficiency excluded via urinary pterin analysis (PMID N/A - linked article; PP4_Moderate). This variant was detected with L249F (reported as Pathogenic in ClinVar; VarID:102821; 7 submitters) and R270K (reported as Pathogenic in ClinVar; VarID:102846; 5 submitters) - phase not confirmed - 1.0 points (PMID N/A - linked article; PM3). This variant is absent from population databases (PM2). This variant is predicted deleterious by SIFT, PolyPhen2, MutationTaster, and REVEL = 0.99. In summary, this variant meets criteria to be classified as Likely Pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PP4_Moderate, PM3, PP3.

PP4_Moderate

Linked article - F410C detected in two Portuguese patients with moderate PKU (serum Phe = 6.6mg/dL and 15.0mg/dL); BH4 deficiency excluded via urinary pterin analysis

PubMed:18798839

PP3

Variant predicted deleterious by SIFT, PolyPhen2, MutationTaster, and REVEL = 0.99.

PM2

Variant absent from population databases.

PM3

Linked article - F410C detected with L249F (reported as Pathogenic in ClinVar; VarID:102821; 7 submitters) and R270K (reported as Pathogenic in ClinVar; VarID:102846; 5 submitters) - phase not confirmed - 1.0 points

PM5

Variant as same amino acid residue as NM_000277.3(PAH):c.1229T>C (p.Phe410Ser) (ClinVarID:102571, VUS, 2 submitters, not yet curated by ClinGen PAH VCEP) and c.1228T>A (p.Phe410Ile) which is not reported in ClinVar and has been curated as Likely Pathogenic by ClinGen PAH VCEP

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.